Research News for January 4, 2023
advertisement
- Decorin improves human pancreatic β-cell function and regulates ECM expression in vitro
- Development of Type 1 Diabetes may occur through a Type 2 Diabetes mechanism (Full text HTML)
- Genetic polymorphisms of Endoplasmic reticulum amino peptidase 1 (ERAP1) and Interferon lambda 4 (IFN-λ4) in Egyptian patients with type 1 diabetes mellitus
- The emerging role of regulatory cell-based therapy in autoimmune disease (Full text HTML)
- A Mendelian randomization study to assess the genetic liability of type 1 diabetes mellitus for IgA nephropathy (Full text HTML)
- The emerging role of regulatory cell-based therapy in autoimmune disease (Full text HTML)
- Affinity purification of serum-derived anti-IA-2 autoantibodies in type 1 diabetes using a novel MBP-IA-2 fusion protein (Full text HTML, PDF)
- Alterations of oral microbiota and impact on the gut microbiome in type 1 diabetes mellitus revealed by integrated multi-omic analyses
- Two-Year Follow-up From the T1GER Study: Continued Off-Therapy Metabolic Improvements in Children and Young Adults With New-Onset T1D Treated With Golimumab and Characterization of Responders
- Circulating Small Noncoding RNA Profiling as a Potential Biomarker of Atherosclerotic Plaque Composition in Type 1 Diabetes
